Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Yajneon Oct 06, 2022 9:59pm
273 Views
Post# 35011310

RE:RE:Dr, MacFarland

RE:RE:Dr, MacFarlandnow 2b7fb6fab, that sounds like something worth 'fact checking', although I doubt that the public domain contains the info necessary to do the fact check on your assertion...

2b7f6fab wrote: Correct me please if I have it wrong.  But my understanding is that Dr MacFarland tried marketing her invention to big pharma but there were no takers.  Only RW saw the potential.

jmm1228 wrote:

She is, I think, the patent holder and scientist who  granted the license of her discovery to TLT. 

I wonder what her expectations were when she did this and how she views the activity on her behalf since, and what her expectations were then and how she views the fulfillment of them to date.

It is pretty much a given that she has delivered a potentially brilliant treatment in the cancer realm.

The implementation of her brilliance does not parallel her discovery.

 I expect she would welcome a better market pathmaker after the near term approval process confirms the efficacy of her brilliant work.

This matter has a need for excellence of leadership as the "moment critique" must be deftly handled.

Who is going to crack the whip?

 


 





<< Previous
Bullboard Posts
Next >>